Symphogen AS - Strategic SWOT Analysis Review
DESCRIPTION
TABLE OF CONTENTS
RELATED REPORTS
SAMPLE REQUEST
REVIEWS
DESCRIPTION
Symphogen AS - Strategic SWOT Analysis Review provides a comprehensive insight into the companys history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the companys key employees, key competitors and major products and services.
This up-to-the-minute company report will help you to formulate strategies to drive your business by enabling you to understand your partners, customers and competitors better.
Scope
- Business description A detailed description of the companys operations and business divisions.
- Corporate strategy GlobalDatas summarization of the companys business strategy.
- SWOT analysis A detailed analysis of the companys strengths, weakness, opportunities and threats.
- Company history Progression of key events associated with the company.
- Major products and services A list of major products, services and brands of the company.
- Key competitors A list of key competitors to the company.
- Key employees A list of the key executives of the company.
- Executive biographies A brief summary of the executives employment history.
- Key operational heads A list of personnel heading key departments/functions.
- Important locations and subsidiaries A list of key locations and subsidiaries of the company, including contact details.
Highlights
Symphogen A/S (Symphogen) is a biopharmaceutical company that specializes in the field of recombinant antibody mixtures for therapeutic use in cancer. The company focuses on developing superior monoclonal antibody (mAb) mixture therapeutics. The product pipeline provides novel approaches to a wide range of cancer types including metastatic colorectal cancer (mCRC), solid tumor malignancies and lung cancer. It has collaborations for the development of antibody therapeutics in immuno-oncology with Shire and infectious disease area with Genentech. The company has offices in Denmark and New Jersey, the US. Symphogen is headquartered in Ballerup, Denmark.
Symphogen AS Key Recent Developments
Apr 06,2020: Servier agrees to acquire Symphogen
Reasons to Buy
- Gain key insights into the company for academic or business research purposes. Key elements such as SWOT analysis and corporate strategy are incorporated in the profile to assist your academic or business research needs.
- Identify potential customers and suppliers with this reports analysis of the companys business structure, operations, major products and services and business strategy.
- Understand and respond to your competitors business structure and strategies with GlobalDatas detailed SWOT analysis. In this, the companys core strengths, weaknesses, opportunities and threats are analyzed, providing you with an up to date objective view of the company.
- Examine potential investment and acquisition targets with this reports detailed insight into the companys strategic, business and operational performance.
Note: Some sections may be missing if data is unavailable for the company.
This up-to-the-minute company report will help you to formulate strategies to drive your business by enabling you to understand your partners, customers and competitors better.
Scope
- Business description A detailed description of the companys operations and business divisions.
- Corporate strategy GlobalDatas summarization of the companys business strategy.
- SWOT analysis A detailed analysis of the companys strengths, weakness, opportunities and threats.
- Company history Progression of key events associated with the company.
- Major products and services A list of major products, services and brands of the company.
- Key competitors A list of key competitors to the company.
- Key employees A list of the key executives of the company.
- Executive biographies A brief summary of the executives employment history.
- Key operational heads A list of personnel heading key departments/functions.
- Important locations and subsidiaries A list of key locations and subsidiaries of the company, including contact details.
Highlights
Symphogen A/S (Symphogen) is a biopharmaceutical company that specializes in the field of recombinant antibody mixtures for therapeutic use in cancer. The company focuses on developing superior monoclonal antibody (mAb) mixture therapeutics. The product pipeline provides novel approaches to a wide range of cancer types including metastatic colorectal cancer (mCRC), solid tumor malignancies and lung cancer. It has collaborations for the development of antibody therapeutics in immuno-oncology with Shire and infectious disease area with Genentech. The company has offices in Denmark and New Jersey, the US. Symphogen is headquartered in Ballerup, Denmark.
Symphogen AS Key Recent Developments
Apr 06,2020: Servier agrees to acquire Symphogen
Reasons to Buy
- Gain key insights into the company for academic or business research purposes. Key elements such as SWOT analysis and corporate strategy are incorporated in the profile to assist your academic or business research needs.
- Identify potential customers and suppliers with this reports analysis of the companys business structure, operations, major products and services and business strategy.
- Understand and respond to your competitors business structure and strategies with GlobalDatas detailed SWOT analysis. In this, the companys core strengths, weaknesses, opportunities and threats are analyzed, providing you with an up to date objective view of the company.
- Examine potential investment and acquisition targets with this reports detailed insight into the companys strategic, business and operational performance.
Note: Some sections may be missing if data is unavailable for the company.
TABLE OF CONTENTS
Table of Contents
List of Tables
List of Figures
Section 1 - About the Company
Symphogen A/S - Key Facts
Symphogen A/S - Key Employees
Symphogen A/S - Major Products and Services
Symphogen A/S - History
Symphogen A/S - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Section 2 Company Analysis
Company Overview
Symphogen A/S - Business Description
Symphogen A/S - SWOT Analysis
SWOT Analysis - Overview
Symphogen A/S - Strengths
Symphogen A/S - Weaknesses
Symphogen A/S - Opportunities
Symphogen A/S - Threats
Symphogen A/S - Key Competitors
Section 3 Companys Lifesciences Financial Deals and Alliances
Symphogen A/S, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
Symphogen A/S, Pharmaceuticals & Healthcare, Deals By Type, 2015 to YTD 2021
Symphogen A/S, Recent Deals Summary
Section 4 Companys Recent Developments
Apr 06, 2020: Servier agrees to acquire Symphogen
Section 5 Appendix
Methodology
About GlobalData
Contact Us
Disclaimer
Symphogen A/S, Key Facts
Symphogen A/S, Key Employees
Symphogen A/S, Major Products and Services
Symphogen A/S, History
Symphogen A/S, Subsidiaries
Symphogen A/S, Key Competitors
Symphogen A/S, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
Symphogen A/S, Pharmaceuticals & Healthcare, Deals By Type, 2015 to YTD 2021
Symphogen A/S, Recent Deals Summary
Symphogen A/S, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
Symphogen A/S, Pharmaceuticals & Healthcare, Deals by Type, 2015 to YTD 2021
List of Tables
List of Figures
Section 1 - About the Company
Symphogen A/S - Key Facts
Symphogen A/S - Key Employees
Symphogen A/S - Major Products and Services
Symphogen A/S - History
Symphogen A/S - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Section 2 Company Analysis
Company Overview
Symphogen A/S - Business Description
Symphogen A/S - SWOT Analysis
SWOT Analysis - Overview
Symphogen A/S - Strengths
Symphogen A/S - Weaknesses
Symphogen A/S - Opportunities
Symphogen A/S - Threats
Symphogen A/S - Key Competitors
Section 3 Companys Lifesciences Financial Deals and Alliances
Symphogen A/S, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
Symphogen A/S, Pharmaceuticals & Healthcare, Deals By Type, 2015 to YTD 2021
Symphogen A/S, Recent Deals Summary
Section 4 Companys Recent Developments
Apr 06, 2020: Servier agrees to acquire Symphogen
Section 5 Appendix
Methodology
About GlobalData
Contact Us
Disclaimer
List Of Tables
List of TablesSymphogen A/S, Key Facts
Symphogen A/S, Key Employees
Symphogen A/S, Major Products and Services
Symphogen A/S, History
Symphogen A/S, Subsidiaries
Symphogen A/S, Key Competitors
Symphogen A/S, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
Symphogen A/S, Pharmaceuticals & Healthcare, Deals By Type, 2015 to YTD 2021
Symphogen A/S, Recent Deals Summary
List Of Figures
List of FiguresSymphogen A/S, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
Symphogen A/S, Pharmaceuticals & Healthcare, Deals by Type, 2015 to YTD 2021
RELATED REPORTS
Managed and Professional Security Services Market in Americas - 2023 Edition
Cybersecurity is the protection of internet-connected systems such as hardware, software and data from cyberthreats. The practice is used by individuals and enterprises to protect against unauthorized access to data
View ReportAluminium Composite Panel Market in Americas - 2022 Edition
According to market research study published by Gen Consulting Company, the aluminium composite panel market in Americas stood at around USD 2,366 million in 2021 and is projected to rise
View ReportSAMPLE REQUEST
Fill The Form For Sample Request
REVIEWS
